Cardiologists find a novel use for pacemakers
This article was originally published in Clinica
A multinational group of cardiologists says pacemakers can be used to treat hypertrophic obstructive cardiomyopathy (HOCM), a disease which can strike at any age and is the most common cause of sudden death in athletes. HOCM is caused by the thickening of the heart's ventricular walls. Eventually the thickening obstructs the flow of blood so much that the left ventricle can no longer satisfy the body's need for oxygen.
You may also be interested in...
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.
The FDA has released final guidance on “Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA” for the industry. The guidance brings clarity and aims at facilitating product development meetings between the FDA and the ANDA applicants for complex products.
By handing out free supplements to the clinically vulnerable, the UK government is effectively endorsing the use of vitamin D to reduce the risk and/or severity of COVID-19, although it says more research is needed.